CAR-T cell therapy is a personalized treatment where a patient's T cells are modified in the laboratory to express a receptor specific to cancer cells. These engineered T cells are then infused back into the patient to attack the cancer. This therapy has shown remarkable success in treating certain types of blood cancers, such as leukemia and lymphoma.
